XML 12 R4.htm IDEA: XBRL DOCUMENT v3.22.4
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
 3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Operating expenses              
Research and development $ (14,298,925) $ (2,805,955) $ (33,830,890) $ (6,636,418) $ (13,279,780) $ (8,358,043) $ (5,947,294)
General and administrative expenses         (4,898,942) (1,233,876) (1,739,815)
Selling, general and administrative (6,845,045) (939,106) (23,892,011) (3,265,612) (4,898,942) (1,233,876) (1,739,815)
New Warrants expenses (17,424,230) 0 (104,776,230) 0      
Loss from operations (38,568,200) (3,745,061) (162,499,131) (9,902,030) (18,178,722) (9,591,919) (7,687,109)
Change in fair value of derivative liabilities 285,000 0 6,127,500 0
Financial and foreign exchange gain/(loss), net 2,028,854 (14,041) 3,015,420 (57,914) (77,147) (34,023) 1,590
Loss before income taxes (36,254,346) (3,759,102) (153,356,211) (9,959,944) (18,255,869) (9,625,942) (7,685,519)
Income tax expense (490,376) 0 (620,084) 0 0 0 0
Net income (loss) $ (36,744,722) $ (3,759,102) $ (153,976,295) $ (9,959,944) $ (18,255,869) $ (9,625,942) $ (7,685,519)
Net income (loss) per share basic $ (0.14) $ (0.02) $ (0.62) $ (0.05)      
Net income (loss) per share diluted $ (0.14) $ (0.02) $ (0.62) $ (0.05)      
Weighted average number of shares outstanding basic 272,040,343 220,000,000 247,010,044 220,000,000      
Weighted average number of shares outstanding diluted 272,040,343 220,000,000 247,010,044 220,000,000